🔎 Trials Near Me

መነሻ › ኖን-ስማል ሴል የሳንባ ካንሰር › ሚኔሶታ › Rochester

በRochester፣ MN ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ 37 ጥናቶች በRochester እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic-Rochester /ID# 274512, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06772623

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06996782

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #68, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06918132

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic - Rochester ( Site 0073), Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06312137

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic - Rochester ( Site 0148), Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06170788

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04981119

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07154290

An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic, Rochester
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06693336

Pan-tumor MRD Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06605404

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06692738

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06899126

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic (Rochester), Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05059444

A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT04302025

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07361562

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07291037

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT05245500

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic - Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT04913285

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07027514

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic-Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06892548

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06122064

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06500481

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic Hospital - Rochester, MN, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT06706076

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic Rochester, Rochester
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06562192

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic Cancer Center, Rochester
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06131840

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT06686771

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT06051695

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Mayo Clinic Comprehensive Cancer Center, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁን 2026 · NCT06026410

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT07154706

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06660407

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic Cancer Center, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06810544

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06418204

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT06349642

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mayo Clinic (Data Collection Only), Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ፌብሩ 2026 · NCT07428044

Insomnia in Patients With Metastatic Lung Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Mayo Clinic in Rochester, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ፌብሩ 2026 · NCT06472804

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Mayo Clinic, Rochester
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2025 · NCT06682793

በሌሎች ከተሞች ለኖን-ስማል ሴል የሳንባ ካንሰር የሚደረጉ ጥናቶች

በRochester ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።